Citations (113)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Nathan C. Stam, Jennifer L. Pilgrim, Olaf H. Drummer, Karen Smith & Dimitri Gerostamoulos. (2018) Catch and release: evaluating the safety of non-fatal heroin overdose management in the out-of-hospital environment. Clinical Toxicology 56:11, pages 1135-1142.
Read now
Read now
Carley Marshall, Myra Piat & Michel Perreault. (2018) Exploring the psychological benefits and challenges experienced by peer-helpers participating in take-home naloxone programmes: A rapid review. Drugs: Education, Prevention and Policy 25:3, pages 280-291.
Read now
Read now
Ryan M. Jeffery, Laura Dickinson, Nicholas D. Ng, Lindsey M. DeGeorge & Jose V. Nable. (2017) Naloxone administration for suspected opioid overdose: An expanded scope of practice by a basic life support collegiate-based emergency medical services agency. Journal of American College Health 65:3, pages 212-216.
Read now
Read now
Lisham Ashrafioun, Stephanie Gamble, Michele Herrmann & Gloria Baciewicz. (2016) Evaluation of knowledge and confidence following opioid overdose prevention training: A comparison of types of training participants and naloxone administration methods. Substance Abuse 37:1, pages 76-81.
Read now
Read now
Michael Soyka. (2015) New developments in the management of opioid dependence: focus on sublingual buprenorphine–naloxone. Substance Abuse and Rehabilitation 6, pages 1-14.
Read now
Read now
Hong K Kim & Lewis S Nelson. (2015) Reducing the harm of opioid overdose with the safe use of naloxone: a pharmacologic review. Expert Opinion on Drug Safety 14:7, pages 1137-1146.
Read now
Read now
Sharon Stancliff, Benjamin W. Phillips, Nazlee Maghsoudi & Herman Joseph. (2015) Harm Reduction: Front Line Public Health. Journal of Addictive Diseases 34:2-3, pages 206-219.
Read now
Read now
Michael Soyka. (2015) Buprenorphine–naloxone buccal soluble film for the treatment of opioid dependence: current update. Expert Opinion on Drug Delivery 12:2, pages 339-347.
Read now
Read now
Sebastiano Mercadante & Antonello Giarratano. (2013) Combined oral prolonged-release oxycodone and naloxone in chronic pain management. Expert Opinion on Investigational Drugs 22:1, pages 161-166.
Read now
Read now
Michael Soyka, Henry R. Kranzler, Wim van den Brink, John Krystal, Hans-Jürgen Möller & Siegfried Kasper. (2011) The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Substance Use and Related Disorders. Part 2: Opioid dependence. The World Journal of Biological Psychiatry 12:3, pages 160-187.
Read now
Read now
Katri Elina Clemens & Gerd Mikus. (2010) Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain. Expert Opinion on Pharmacotherapy 11:2, pages 297-310.
Read now
Read now
Articles from other publishers (102)
Piyusha P. Pagare, Rachael Flammia & Yan Zhang. (2023) IUPHAR review: Recent Progress in the Development of Mu Opioid Receptor Modulators to Treat Opioid Use Disorders. Pharmacological Research, pages 107023.
Crossref
Crossref
Kawther Magdy Ibrahim, Hebatalla I. Ahmed, Laila Ramadan & Amany Balah. (2023) A low dose of naloxone mitigates autoimmune hepatitis by regulating TLR4/NF-κB and Nrf2/HO-1 signaling pathways. Inflammopharmacology.
Crossref
Crossref
Maarten van Lemmen, Jeffrey Florian, Zhihua Li, Monique van Velzen, Eveline van Dorp, Marieke Niesters, Elise Sarton, Erik Olofsen, Rutger van der Schrier, David G. Strauss & Albert Dahan. (2023) Opioid Overdose: Limitations in Naloxone Reversal of Respiratory Depression and Prevention of Cardiac Arrest. Anesthesiology 139:3, pages 342-353.
Crossref
Crossref
Bianca Yugar, Kelly McManus, Christine Ramdin, Lewis S. Nelson & Mehruba Anwar Parris. (2023) Systematic Review of Naloxone Dosing and Adverse Events in the Emergency Department. The Journal of Emergency Medicine 65:3, pages e188-e198.
Crossref
Crossref
Omar B. Sanchez-Reyes, Gregory Zilberg, John D. McCorvy & Daniel Wacker. (2023) Molecular insights into GPCR mechanisms for drugs of abuse. Journal of Biological Chemistry 299:9, pages 105176.
Crossref
Crossref
Damian Kobylarz, Maciej Noga, Adrian Frydrych, Justyna Milan, Adrian Morawiec, Agata Glaca, Emilia Kucab, Julia Jastrzębska, Karolina Jabłońska, Klaudia Łuc, Gabriela Zdeb, Jakub Pasierb, Joanna Toporowska-Kaźmierak, Szczepan Półchłopek, Paweł Słoma, Magdalena Adamik, Mateusz Banasik, Mateusz Bartoszek, Aleksandra Adamczyk, Patrycja Rędziniak, Paulina Frączkiewicz, Michał Orczyk, Martyna Orzechowska, Paulina Tajchman, Klaudia Dziuba, Rafał Pelczar, Sabina Zima, Yana Nyankovska, Marta Sowińska, Wiktoria Pempuś, Maria Kubacka, Julia Popielska, Patryk Brzezicki & Kamil Jurowski. (2023) Antidotes in Clinical Toxicology—Critical Review. Toxics 11:9, pages 723.
Crossref
Crossref
Xiaohan Jiang, Qiang Yang, Ruogu Qi & Lesan Yan. (2023) Nanoparticle-Mediated Delivery of Satraplatin to Overcome Cisplatin Drug Resistance. Journal of Functional Biomaterials 14:7, pages 387.
Crossref
Crossref
Yu Mi Park, Markus R. Meyer, Rolf Müller & Jennifer Herrmann. (2023) Optimization of Mass Spectrometry Imaging for Drug Metabolism and Distribution Studies in the Zebrafish Larvae Model: A Case Study with the Opioid Antagonist Naloxone. International Journal of Molecular Sciences 24:12, pages 10076.
Crossref
Crossref
M Cristina Benéitez García, Rocío Girón Moreno, Inés Colmena Crespo, Rosalía M Díez-Orejas, M Isabel Martín Fontelles, Carlos Goicoechea García, Eva M Sánchez-Robles & M Esther Gil-Alegre. (2023) Promising biomedical subcutaneous delivery system in opioid disaccustom process: In vitro/in vivo evaluation of naloxone microparticles on antagonist effect of morphine. International Journal of Pharmaceutics 635, pages 122766.
Crossref
Crossref
Harrison J. Elder, Neil B. Varshneya, D. Matthew Walentiny & Patrick M. Beardsley. (2023) Amphetamines modulate fentanyl-depressed respiration in a bidirectional manner. Drug and Alcohol Dependence 243, pages 109740.
Crossref
Crossref
Jinghan Yang, Hui Ding, Bo Shuai, Yan Zhang & Yan Zhang. (2023) Mechanism and effects of STING–IFN-I pathway on nociception: A narrative review. Frontiers in Molecular Neuroscience 15.
Crossref
Crossref
Kimberly Chieh, Ishika Patel, Lauren Walter & Li Li. (2022) Disparities in naloxone prescriptions in a University Hospital during the COVID-19 pandemic. Harm Reduction Journal 19:1.
Crossref
Crossref
Tristan H.J. Lewis, Walter J. May, Alex P. Young, James N. Bates, Santhosh M. Baby, Paulina M. Getsy, Rita M. Ryan, Yee-Hsee Hsieh, James M. Seckler & Stephen J. Lewis. (2022) The ventilatory depressant actions but not the antinociceptive effects of morphine are blunted in rats receiving intravenous infusion of L-cysteine ethyl ester. Biomedicine & Pharmacotherapy 156, pages 113939.
Crossref
Crossref
Kebede Beyene, Wilson Shen, Terry Mitchell, Scott Gilson, Stella Kang, Daniel Lai, Liandra Misquitta, Atifa Slaimankhel & Amy Hai Yan Chan. (2022) Risk factors for opioid toxicity requiring naloxone rescue in adults: a case-control study. International Journal of Clinical Pharmacy 44:6, pages 1296-1303.
Crossref
Crossref
Piyusha P. Pagare, Samuel Obeng, Boshi Huang, Madison M. Marcus, Katherine L. Nicholson, Andrew E. Townsend, Matthew L. Banks & Yan Zhang. (2022) Preclinical Characterization and Development on NAQ as a Mu Opioid Receptor Partial Agonist for Opioid Use Disorder Treatment. ACS Pharmacology & Translational Science 5:11, pages 1197-1209.
Crossref
Crossref
Mehmet Hamdi Orum, Aysun Kalenderoglu, Ayse Sevgi Karadag & Cicek Hocaoglu. (2022) Retinal nerve fiber layer decrease and choroidal layer increase after four weeks of buprenorphine/naloxone maintenance treatment in opioid use disorder. The European Journal of Psychiatry 36:4, pages 260-270.
Crossref
Crossref
Paulina M. Getsy, Santhosh M. Baby, Walter J. May, James N. Bates, Christopher R. Ellis, Michael G. Feasel, Christopher G. Wilson, Tristan H. J. Lewis, Benjamin Gaston, Yee-Hsee Hsieh & Stephen J. Lewis. (2022) L-cysteine methyl ester overcomes the deleterious effects of morphine on ventilatory parameters and arterial blood-gas chemistry in unanesthetized rats. Frontiers in Pharmacology 13.
Crossref
Crossref
Paulina M. Getsy, Santhosh M. Baby, Walter J. May, Tristan H.J. Lewis, James N. Bates, Yee-Hsee Hsieh, Benjamin Gaston & Stephen J. Lewis. (2022) L-NAC reverses of the adverse effects of fentanyl infusion on ventilation and blood-gas chemistry. Biomedicine & Pharmacotherapy 153, pages 113277.
Crossref
Crossref
Xin Zhang, Meng-Yang Sun, Xue Zhang, Chang-Run Guo, Yun-Tao Lei, Wen-Hui Wang, Ying-Zhe Fan, Peng Cao, Chang-Zhu Li, Rui Wang, Xing-Hua Li, Ye Yu & Xiao-Na Yang. (2022) Dynamic recognition of naloxone, morphine and endomorphin1 in the same pocket of µ-opioid receptors. Frontiers in Molecular Biosciences 9.
Crossref
Crossref
Paulina M. Getsy, Santhosh M. Baby, Walter J. May, Alex P. Young, Benjamin Gaston, Matthew R. Hodges, Hubert V. Forster, James N. Bates, Christopher G. Wilson, Tristan H. J. Lewis, Yee-Hee Hsieh & Stephen J. Lewis. (2022) D-Cysteine Ethyl Ester Reverses the Deleterious Effects of Morphine on Breathing and Arterial Blood–Gas Chemistry in Freely-Moving Rats. Frontiers in Pharmacology 13.
Crossref
Crossref
Marieke Hyke Algera, Joseph F. Cotten, Monique van Velzen, Marieke Niesters, Martijn Boon, Daniel S. Shoham, Kaye E. Dandrea, Rutger van der Schrier & Albert Dahan. (2022) Are thyrotropin‐releasing hormone (TRH) and analog taltirelin viable reversal agents of opioid‐induced respiratory depression?. Pharmacology Research & Perspectives 10:3.
Crossref
Crossref
Rutger van der Schrier, Jack D. C. Dahan, Martijn Boon, Elise Sarton, Monique van Velzen, Marieke Niesters & Albert Dahan. (2021) Advances in Reversal Strategies of Opioid-induced Respiratory Toxicity. Anesthesiology 136:4, pages 618-632.
Crossref
Crossref
Piyusha P. Pagare, Mengchu Li, Yi Zheng, Abhishek S. Kulkarni, Samuel Obeng, Boshi Huang, Christian Ruiz, James C. Gillespie, Rolando E. Mendez, David L. Stevens, Justin L. Poklis, Matthew S. Halquist, William L. Dewey, Dana E. Selley & Yan Zhang. (2022) Design, Synthesis, and Biological Evaluation of NAP Isosteres: A Switch from Peripheral to Central Nervous System Acting Mu-Opioid Receptor Antagonists. Journal of Medicinal Chemistry 65:6, pages 5095-5112.
Crossref
Crossref
Nicholas T. Lappas & Courtney M. Lappas. 2022. Forensic Toxicology. Forensic Toxicology
45
71
.
J. Blake Calcei, Michael P. Powers, Shawn Clark & John R. Gusz. 2022. Peterson’s Principles of Oral and Maxillofacial Surgery. Peterson’s Principles of Oral and Maxillofacial Surgery
473
513
.
Carlos D. Rivera Saldana, Daniela Abramovitz, Meredith C. Meacham, Patricia Gonzalez‐Zuniga, Claudia Rafful, Gudelia Rangel, Steffanie A. Strathdee & Javier Cepeda. (2021) Risk of non‐fatal overdose and polysubstance use in a longitudinal study with people who inject drugs in Tijuana, Mexico. Drug and Alcohol Review 40:7, pages 1340-1348.
Crossref
Crossref
Leila Ahmad-Molaei, Mahsa Pourhamzeh, Reza Ahadi, Fariba Khodagholi, Hossein Hassanian-Moghaddam & Abbas Haghparast. (2020) Time-Dependent Changes in the Serum Levels of Neurobiochemical Factors After Acute Methadone Overdose in Adolescent Male Rat. Cellular and Molecular Neurobiology 41:8, pages 1635-1649.
Crossref
Crossref
Nicholas B. Miner, William E. Schutzer, Yalda Zarnegarnia, Aaron Janowsky & Randy Torralva. (2021) Fentanyl causes naloxone-resistant vocal cord closure: A platform for testing opioid overdose treatments. Drug and Alcohol Dependence 227, pages 108974.
Crossref
Crossref
Hyeri Park, Jinny Claire Lee, Lisa M. Eubanks, Beverly Ellis, Bin Zhou & Kim D. Janda. (2021) Improvements on a chemically contiguous hapten for a vaccine to address fentanyl-contaminated heroin. Bioorganic & Medicinal Chemistry 41, pages 116225.
Crossref
Crossref
Jan-Marino Ramirez, Nicholas J. Burgraff, Aguan D. Wei, Nathan A. Baertsch, Adrienn G. Varga, Helen A. Baghdoyan, Ralph Lydic, Kendall F. Morris, Donald C. Bolser & Erica S. Levitt. (2021) Neuronal mechanisms underlying opioid-induced respiratory depression: our current understanding. Journal of Neurophysiology 125:5, pages 1899-1919.
Crossref
Crossref
Matthew Jones, Fiona Bell, Jonathan Benger, Sarah Black, Penny Buykx, Simon Dixon, Tim Driscoll, Bridie Evans, Adrian Edwards, Gordon Fuller, Steve Goodacre, Rebecca Hoskins, Jane Hughes, Ann John, Jenna Jones, Chris Moore, Fiona Sampson, Alan Watkins & Helen Snooks. (2020) Protocol for Take-home naloxone In Multicentre Emergency (TIME) settings: feasibility study. Pilot and Feasibility Studies 6:1.
Crossref
Crossref
Aaron Skolnik & Jessica Monas. (2020) The Crashing Toxicology Patient. Emergency Medicine Clinics of North America 38:4, pages 841-856.
Crossref
Crossref
Carmen A. ZavalaAna C. ThomazVishakh IyerKen MackieAndrea G. Hohmann. (2020)
Cannabinoid CB
2
Receptor Activation Attenuates Fentanyl-Induced Respiratory Depression
. Cannabis and Cannabinoid Research.
Crossref
Crossref
Jiasi Chen, Jingmin Qin, Qinghua He & Zhiling Zou. (2020) A Meta-Analysis of Transcranial Direct Current Stimulation on Substance and Food Craving: What Effect Do Modulators Have?. Frontiers in Psychiatry 11.
Crossref
Crossref
Jiaxing Wang, Beverly Ellis, Bin Zhou, Lisa M. Eubanks, Steven Blake & Kim D. Janda. (2020) A fentanyl vaccine constructed upon opsonizing antibodies specific for the Galα1–3Gal epitope. Chemical Communications 56:48, pages 6551-6554.
Crossref
Crossref
Maria Carmen Blanco-Gandía, Sandra Montagud-Romero & Marta Rodríguez-Arias. 2020. Opioids - From Analgesic Use to Addiction. Opioids - From Analgesic Use to Addiction.
Belin G. Teklezgi, Annapurna Pamreddy, Sphamandla Ntshangase, Sipho Mdanda, Sanil D. Singh, Nirmala D. Gopal, Tricia Naicker, Hendrik G. Kruger, Thavendran Govender & Sooraj Baijnath. (2020) Mass Spectrometric Imaging of the Brain Demonstrates the Regional Displacement of 6-Monoacetylmorphine by Naloxone. ACS Omega 5:22, pages 12596-12602.
Crossref
Crossref
Qiushi Li, Sukanya Ramasamy, Pooja Singh, Jillian M. Hagel, Sonja M. Dunemann, Xue Chen, Rongji Chen, Lisa Yu, Joseph E. Tucker, Peter J. Facchini & Sam Yeaman. (2020) Gene clustering and copy number variation in alkaloid metabolic pathways of opium poppy. Nature Communications 11:1.
Crossref
Crossref
Jessica Moe, Jesse Godwin, Roy Purssell, Fiona O'Sullivan, Jeffrey P. Hau, Elizabeth Purssell, Jason Curran, Mary M. Doyle-Waters, Penelope M.A. Brasher, Jane A. Buxton & Corinne M. Hohl. (2020) Naloxone dosing in the era of ultra-potent opioid overdoses: a systematic review. CJEM 22:2, pages 178-186.
Crossref
Crossref
Rosanna Smart, Courtney A. Kase, Erin A. Taylor, Susan Lumsden, Scott R. Smith & Bradley D. Stein. (2020) Strengths and weaknesses of existing data sources to support research to address the opioids crisis. Preventive Medicine Reports 17, pages 101015.
Crossref
Crossref
Keith Harris, Colin B Page, Sikta Samantray, Lachlan Parker, Andrew JA Brier & Katherine Z Isoardi. (2019) One single large intramuscular dose of naloxone is effective and safe in suspected heroin poisoning. Emergency Medicine Australasia 32:1, pages 88-92.
Crossref
Crossref
Lindsay Victoria Shaw, Jessica Moe, Roy Purssell, Jane A. Buxton, Jesse Godwin, Mary M. Doyle-Waters, Penelope M. A. Brasher, Jeffrey P. Hau, Jason Curran & Corinne M. Hohl. (2019) Naloxone interventions in opioid overdoses: a systematic review protocol. Systematic Reviews 8:1.
Crossref
Crossref
Yi Zheng, Samuel Obeng, Bethany A. Reinecke, Chongguang Chen, Palak S. Phansalkar, David M. Walentiny, Phillip M. Gerk, Lee-Yuan Liu-Chen, Dana E. Selley, Patrick M. Beardsley & Yan Zhang. (2019) Pharmacological characterization of 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-[(3′-fluoro-4′-pyridyl)acetamido]morphinan (NFP) as a dual selective MOR/KOR ligand with potential applications in treating opioid use disorder. European Journal of Pharmacology 865, pages 172812.
Crossref
Crossref
Chloe J. Jordan, Jianjing Cao, Amy Hauck Newman & Zheng-Xiong Xi. (2019) Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine. Neuropharmacology 158, pages 107609.
Crossref
Crossref
John J. Lewin, Mohit Datta & Geoffrey S. F. Ling. 2019. Neurocritical Care. Neurocritical Care
254
268
.
Jun RenXiuqing DingJohn J. Greer. (2019) Activating α4β2 Nicotinic Acetylcholine Receptors Alleviates Fentanyl-induced Respiratory Depression in Rats. Anesthesiology 130:6, pages 1017-1031.
Crossref
Crossref
Marijke Hyke Algera, Jasper Kamp, Rutger van der Schrier, Monique van Velzen, Marieke Niesters, Leon Aarts, Albert Dahan & Erik Olofsen. (2019) Opioid-induced respiratory depression in humans: a review of pharmacokinetic–pharmacodynamic modelling of reversal. British Journal of Anaesthesia 122:6, pages e168-e179.
Crossref
Crossref
Samuel Obeng, Abdulmajeed Jali, Yi Zheng, Huiqun Wang, Kathryn L. Schwienteck, Chongguang Chen, David L. Stevens, Hamid I. Akbarali, William L. Dewey, Mathew L. Banks, Lee-Yuan Liu-Chen, Dana E. Selley & Yan Zhang. (2019) Characterization of 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(indole-7-carboxamido)morphinan (NAN) as a Novel Opioid Receptor Modulator for Opioid Use Disorder Treatment. ACS Chemical Neuroscience 10:5, pages 2518-2532.
Crossref
Crossref
Laura Vearrier. (2019) The value of harm reduction for injection drug use: A clinical and public health ethics analysis. Disease-a-Month 65:5, pages 119-141.
Crossref
Crossref
Wei Dai, Xiang Gao, Dian Xiao, Yu-Lei Li, Xin-Bo Zhou, Zheng Yong & Rui-Bin Su. (2019) The Impact and Mechanism of a Novel Allosteric AMPA Receptor Modulator LCX001 on Protection Against Respiratory Depression in Rodents. Frontiers in Pharmacology 10.
Crossref
Crossref
Polyanna dos Santos Negreiros, Douglas Soares da Costa, Valdelânia Gomes da Silva, Izabela Borges de Carvalho Lima, Daniel Barbosa Nunes, Francisca Beatriz de Melo Sousa, Thiago de Souza Lopes Araújo, Jand Venes Rolim Medeiros, Rosimeire Ferreira dos Santos & Rita de Cássia Meneses Oliveira. (2019) Antidiarrheal activity of α-terpineol in mice. Biomedicine & Pharmacotherapy 110, pages 631-640.
Crossref
Crossref
Yi Zheng, Samuel Obeng, Huiqun Wang, Abdulmajeed M. Jali, Bharath Peddibhotla, Dwight A. Williams, Chuanchun Zou, David L. Stevens, William L. Dewey, Hamid I. Akbarali, Dana E. Selley & Yan Zhang. (2019) Design, Synthesis, and Biological Evaluation of the Third Generation 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4′-pyridyl)carboxamido]morphinan (NAP) Derivatives as μ/κ Opioid Receptor Dual Selective Ligands. Journal of Medicinal Chemistry 62:2, pages 561-574.
Crossref
Crossref
Preet Singh, Kavitha Kongara, David Harding, Neil Ward, Venkata Sayoji Rao Dukkipati, Craig Johnson & Paul Chambers. (2018) Comparison of electroencephalographic changes in response to acute electrical and thermal stimuli with the tail flick and hot plate test in rats administered with opiorphin. BMC Neurology 18:1.
Crossref
Crossref
M. Carmen Blanco-Gandía & Marta Rodríguez-Arias. (2018) Pharmacological treatments for opiate and alcohol addiction: A historical perspective of the last 50 years. European Journal of Pharmacology 836, pages 89-101.
Crossref
Crossref
Candy S. Hwang, Lauren C. Smith, Yoshihiro Natori, Beverly Ellis, Bin Zhou & Kim D. Janda. (2018) Improved Admixture Vaccine of Fentanyl and Heroin Hapten Immunoconjugates: Antinociceptive Evaluation of Fentanyl-Contaminated Heroin. ACS Omega 3:9, pages 11537-11543.
Crossref
Crossref
Kunal Karamchandani, Zyad J. Carr, Anthony Bonavia & Avery Tung. (2018) Critical Care Pain Management in Patients Affected by the Opioid Epidemic: A Review. Annals of the American Thoracic Society 15:9, pages 1016-1023.
Crossref
Crossref
Shawn A Ryan & Robert B Dunne. (2018) Pharmacokinetic properties of intranasal and injectable formulations of naloxone for community use: a systematic review. Pain Management 8:3, pages 231-245.
Crossref
Crossref
Albert DahanRutger van der SchrierTerry SmithLeon AartsMonique van VelzenMarieke Niesters. (2018) Averting Opioid-induced Respiratory Depression without Affecting Analgesia. Anesthesiology 128:5, pages 1027-1037.
Crossref
Crossref
Samuel Obeng, Yunyun Yuan, Abdulmajeed Jali, Dana E. Selley & Yan Zhang. (2018) In vitro and in vivo functional profile characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3-carboxamido)morphinan (NAQ) as a low efficacy mu opioid receptor modulator. European Journal of Pharmacology 827, pages 32-40.
Crossref
Crossref
Julia Goldman-Hasbun, Kora DeBeck, Jane A. Buxton, Ekaterina Nosova, Evan Wood & Thomas Kerr. (2017) Knowledge and possession of take-home naloxone kits among street-involved youth in a Canadian setting: a cohort study. Harm Reduction Journal 14:1.
Crossref
Crossref
Wei Dai, Dian Xiao, Xiang Gao, Xin-Bo Zhou, Tong-Yu Fang, Zheng Yong & Rui-bin Su. (2017) A brain-targeted ampakine compound protects against opioid-induced respiratory depression. European Journal of Pharmacology 809, pages 122-129.
Crossref
Crossref
Yu-Wen Chen, Ja-Ping Shieh, Kuo-Sheng Liu, Jhi-Joung Wang & Ching-Hsia Hung. (2017) Naloxone prolongs cutaneous nociceptive block by lidocaine in rats. Fundamental & Clinical Pharmacology.
Crossref
Crossref
Priyank Shenoy, Andy Kuo, Irina Vetter & Maree T. Smith. (2017) Optimization and In Vivo Profiling of a Refined Rat Model of Walker 256 Breast Cancer Cell-Induced Bone Pain Using Behavioral, Radiological, Histological, Immunohistochemical and Pharmacological Methods. Frontiers in Pharmacology 8.
Crossref
Crossref
Huiqun Wang, Saheem A. Zaidi & Yan Zhang. (2017) Binding mode analyses of NAP derivatives as mu opioid receptor selective ligands through docking studies and molecular dynamics simulation. Bioorganic & Medicinal Chemistry 25:8, pages 2463-2471.
Crossref
Crossref
Corey Davis & Derek Carr. (2017) State legal innovations to encourage naloxone dispensing. Journal of the American Pharmacists Association 57:2, pages S180-S184.
Crossref
Crossref
Carley Marshall, Michel Perreault, Léonie Archambault & Diana Milton. (2017) Experiences of peer-trainers in a take-home naloxone program: Results from a qualitative study. International Journal of Drug Policy 41, pages 19-28.
Crossref
Crossref
M. Cristina Benéitez & M. Esther Gil-Alegre. (2017) Opioid Addiction: Social Problems Associated and Implications of Both Current and Possible Future Treatments, including Polymeric Therapeutics for Giving Up the Habit of Opioid Consumption. BioMed Research International 2017, pages 1-7.
Crossref
Crossref
Rauno Joks & Martin H. Bluth. (2016) Clinical Toxicology and Its Relevance to Asthma and Atopy. Clinics in Laboratory Medicine 36:4, pages 795-801.
Crossref
Crossref
Juliana Lombardi, Eric Villeneuve & Sophie Gosselin. (2016) In Response to: “The Evolution of Recommended Naloxone Dosing for Opioid Overdose by Medical Specialty”. Journal of Medical Toxicology 12:4, pages 412-413.
Crossref
Crossref
Andrew I. Stolbach & Lewis S. Nelson. (2016) Choosing Opioid Policies Our Patients Can Live With. Academic Emergency Medicine 23:11, pages 1290-1292.
Crossref
Crossref
M Roozekrans, E Olofsen, R van der Schrier, J van Gerven, S Peng, J McLeod & A Dahan. (2015) Reversal of opioid-induced respiratory depression by BK-channel blocker GAL021: A pharmacokinetic-pharmacodynamic modeling study in healthy volunteers. Clinical Pharmacology & Therapeutics 97:6, pages 641-649.
Crossref
Crossref
Christina Spofford & David Easker. (2015) Unresponsive Patient in the Post Anesthesia Care Unit. MedEdPORTAL.
Crossref
Crossref
Margot Roozekrans, Rutger van der Schrier, Pieter Okkerse, Justin Hay, James F. McLeod & Albert Dahan. (2014) Two Studies on Reversal of Opioid-induced Respiratory Depression by BK-channel Blocker GAL021 in Human Volunteers. Anesthesiology 121:3, pages 459-468.
Crossref
Crossref
Yan Zhang, Amanda Braithwaite, Yunyun Yuan, John M. Streicher & Edward J. Bilsky. (2014) Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3′-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand. European Journal of Pharmacology 736, pages 124-130.
Crossref
Crossref
Dafna Willner, Ayelet Cohen-Yeshurun, Alexander Avidan, Vladislav Ozersky, Esther Shohami & Ronen R. Leker. (2014) Short Term Morphine Exposure In Vitro Alters Proliferation and Differentiation of Neural Progenitor Cells and Promotes Apoptosis via Mu Receptors. PLoS ONE 9:7, pages e103043.
Crossref
Crossref
Irfanali R. Kugasia & Nehad Shabarek. (2014) Opiate Withdrawal Complicated by Tetany and Cardiac Arrest. Case Reports in Critical Care 2014, pages 1-4.
Crossref
Crossref
Janice E. Sullivan & Mark J. McDonald. 2014. Pediatric Critical Care Medicine. Pediatric Critical Care Medicine
695
727
.
Saheem A. Zaidi, Christopher K. Arnatt, Hengjun He, Dana E. Selley, Philip D. Mosier, Glen E. Kellogg & Yan Zhang. (2013) Binding mode characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives via docking in opioid receptor crystal structures and site-directed mutagenesis studies: Application of the ‘message–address’ concept in development of mu opioid receptor selective antagonists. Bioorganic & Medicinal Chemistry 21:21, pages 6405-6413.
Crossref
Crossref
Ravi V Atreya, Jingchun Sun & Zhongming Zhao. (2013) Exploring drug-target interaction networks of illicit drugs. BMC Genomics 14:S4.
Crossref
Crossref
Michael Soyka. (2013) Buprenorphine Use in Pregnant Opioid Users: A Critical Review. CNS Drugs 27:8, pages 653-662.
Crossref
Crossref
Albert Dahan, Margot Roozekrans, Rutger van der Schrier, Terry Smith & Leon Aarts. (2013) Primum Non Nocere or How to Resolve Drug-induced Respiratory Depression. Anesthesiology 118:6, pages 1261-1263.
Crossref
Crossref
Arjun Chanmugam, Patrick Triplett & Gabor KelenArjun Chanmugam, Dave Milzman, Curtis Bone & Hahn Soe-Lin. 2013. Emergency Psychiatry. Emergency Psychiatry
57
77
.
Frances E. Lennon & Patrick A. Singleton. 2013. Morphine and Metastasis. Morphine and Metastasis
47
61
.
Paul T. Bremer & Kim D. Janda. (2012) Investigating the Effects of a Hydrolytically Stable Hapten and a Th1 Adjuvant on Heroin Vaccine Performance. Journal of Medicinal Chemistry 55:23, pages 10776-10780.
Crossref
Crossref
David J. Martin, Paul E. FitzMorris, Bo Li, Mario Ayestas, Ellicott J. Sally, Christina M. Dersch, Richard B. Rothman & Amy M. Deveau. (2012) An efficient synthesis of 3-OBn-6β,14-epoxy-bridged opiates from naltrexone and identification of a related dual MOR inverse agonist/KOR agonist. Bioorganic & Medicinal Chemistry Letters 22:22, pages 6801-6805.
Crossref
Crossref
Yf Xu, Ll Fu, Ch Jiang, Yw Qin, Yq Ni & Jw Fan. (2012) Naloxone Inhibition of Lipopolysaccharide-Induced Activation of Retinal Microglia is Partly Mediated via the p38 Mitogen Activated Protein Kinase Signalling Pathway. Journal of International Medical Research 40:4, pages 1438-1448.
Crossref
Crossref
Joseph L. D’Orazio & Jason A. Fischel. (2012) Recurrent Respiratory Depression Associated with Fentanyl Transdermal Patch Gel Reservoir Ingestion. The Journal of Emergency Medicine 42:5, pages 543-548.
Crossref
Crossref
C.L. Lassen, W. Zink, C.H.R. Wiese, B.M. Graf & C. Wiesenack. (2012) Naloxoninduziertes LungenödemNaloxone-induced pulmonary edema. Der Anaesthesist 61:2, pages 129-136.
Crossref
Crossref
Veeraindar Goli, Lynn R Webster, Michael J Lamson, Jody M Cleveland, Kenneth W Sommerville & Eric Carter. (2012) Effects of concurrent intravenous morphine sulfate and naltrexone hydrochloride on end-tidal carbon dioxide. Harm Reduction Journal 9:1, pages 13.
Crossref
Crossref
Rie Yamamoto, Shinri Takasuga, Yoshimasa Yoshida, Shoichi Mafune, Katsuya Kominami, Chiyo Sutoh, Yukihiro Kato, Mitsugu Yamauchi, Masao Ito, Kiyoshi Kanamura & Mine Kinoshita. (2012) In vitro and in vivo transdermal iontophoretic delivery of naloxone, an opioid antagonist. International Journal of Pharmaceutics 422:1-2, pages 132-138.
Crossref
Crossref
Gildasio S. De Oliveira, Luke S. Theilken & Robert J. McCarthy. (2011) Shortage of Perioperative Drugs. Anesthesia & Analgesia 113:6, pages 1429-1435.
Crossref
Crossref
J. Hrach, S.O. Mueller & P. Hewitt. (2011) Development of an in vitro liver toxicity prediction model based on longer term primary rat hepatocyte culture. Toxicology Letters 206:2, pages 189-196.
Crossref
Crossref
Dipesh M. Navani, Sunil Sirohi, Priyanka A. Madia & Byron C. Yoburn. (2011) The role of opioid antagonist efficacy and constitutive opioid receptor activity in the opioid withdrawal syndrome in mice. Pharmacology Biochemistry and Behavior 99:4, pages 671-675.
Crossref
Crossref
Bruno M?garbane, Anne Buisine, Fr?d?ric Jacobs, Dabor R?si?re, Lucie Chevillard, Eric Vicaut & Fr?d?ric J. Baud. (2010) Prospective comparative assessment of buprenorphine overdose with heroin and methadone: Clinical characteristics and response to antidotal treatment. Journal of Substance Abuse Treatment 38:4, pages 403-407.
Crossref
Crossref
Lisa J. Merlo, Julia Arana & Amanda M. Stone. 2010. Clinical Trials in Psychopharmacology. Clinical Trials in Psychopharmacology
207
232
.
Albert Dahan, Leon Aarts & Terry W. Smith. (2010) Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression. Anesthesiology 112:1, pages 226-238.
Crossref
Crossref
Vardit Rubovitch, Chaim G Pick & Yosef Sarne. (2009) PRECLINICAL STUDY: Is withdrawal hyperalgesia in morphine‐dependent mice a direct effect of a low concentration of the residual drug?. Addiction Biology 14:4, pages 438-446.
Crossref
Crossref
Sunil Sirohi, Shveta V. Dighe, Priyanka A. Madia & Byron C. Yoburn. (2009) The Relative Potency of Inverse Opioid Agonists and a Neutral Opioid Antagonist in Precipitated Withdrawal and Antagonism of Analgesia and Toxicity. Journal of Pharmacology and Experimental Therapeutics 330:2, pages 513-519.
Crossref
Crossref
Andrea L. Pelotte, Ryan M. Smith, Mario Ayestas, Christina M. Dersch, Edward J. Bilsky, Richard B. Rothman & Amy M. Deveau. (2009) Design, synthesis, and characterization of 6β-naltrexol analogs, and their selectivity for in vitro opioid receptor subtypes. Bioorganic & Medicinal Chemistry Letters 19:10, pages 2811-2814.
Crossref
Crossref
Li Pan, Esperanza J. Carcache de Blanco & A. Douglas Kinghorn. 2009. Plant-derived Natural Products. Plant-derived Natural Products
547
567
.
Ethan O. Bryson & Jeffrey H. Silverstein. (2008) Addiction and Substance Abuse in Anesthesiology. Anesthesiology 109:5, pages 905-917.
Crossref
Crossref
Albert Dahan. (2007) Novel data on opioid effect on breathing and analgesia. Seminars in Anesthesia, Perioperative Medicine and Pain 26:2, pages 58-64.
Crossref
Crossref